SuJen Lai

Person

Burlingame, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirocyclic GPR40 modulators
- Patent number 8,748,462
- Issue date Jun 10, 2014
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted biphenyl GPR40 modulators
- Patent number 8,030,354
- Issue date Oct 4, 2011
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic GPR40 modulators
- Patent number 8,003,648
- Issue date Aug 23, 2011
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic GPR40 modulators
- Patent number 7,714,008
- Issue date May 11, 2010
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC GPR40 MODULATORS
- Publication number 20110190330
- Publication date Aug 4, 2011
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC GPR40 MODULATORS
- Publication number 20100075974
- Publication date Mar 25, 2010
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted biphenyl GPR40 modulators
- Publication number 20090137561
- Publication date May 28, 2009
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic GPR40 Modulators
- Publication number 20080090840
- Publication date Apr 17, 2008
- Amgen Inc.
- Hilary Beck
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Spirocyclic GPR40 modulators

Substituted biphenyl GPR40 modulators

Heterocyclic GPR40 modulators

Heterocyclic GPR40 modulators

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

SPIROCYCLIC GPR40 MODULATORS

HETEROCYCLIC GPR40 MODULATORS

Substituted biphenyl GPR40 modulators

Heterocyclic GPR40 Modulators